MANTLE-CELL LYMPHOMA
Clinical trials for MANTLE-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MANTLE-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MANTLE-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer transplant study tests safer drug combo to prevent deadly complication
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to find which of two drug combinations (cyclosporine and sirolimus with either MMF or post-transplant cyclophosphamide) better prevents a serious side effect call…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
Cord blood transplant shows promise for tough blood cancers
Disease control TerminatedThis study looked at using umbilical cord blood transplants after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. It included 200 people and aimed to see how many survived one year after the transplant. The approach is intense and mean…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Experimental MCL drug trial halted early
Disease control TerminatedThis study tested a new drug called TQB3909 in 19 people with mantle cell lymphoma (MCL) that had come back or stopped responding to treatment. The main goal was to find a safe dose and check for side effects. The trial was ended early, so results are limited.
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC